Cost of medical care for malignant brain tumors at hospitals in the Japan Clinical Oncology Group brain-tumor study group.
Kazuya MotomuraKeita SasakiNarushi SugiiShigeru YamaguchiHirotaka InoueAkito OshimaKazuhiro TanakaYoshihiro OtaniMitsuaki ShirahataIchiyo ShibaharaMotoo NaganeShunsuke TsuzukiTomoo MatsutaniYoshihiro TsukamotoNoriyuki KijimaKenichiro AsanoMakoto OhnoAkihiro InoueYohei MineharuKeisuke MiyakeYuta MitobeMitsuto HaniharaYu KawanishiShoichi DeguchiMasato SaitoRyosuke MatsudaKenta UjifukuHideyuki AritaYuichi SatoShinji YamashitaUshio YonezawaJunya YamaguchiYasutomo MomiiTakahiro OgawaAtsushi KambeShigeo OhbaJunya FukaiNorihiko SaitoMasashi KinoshitaKoichiro SumiRyohei OtaniTakeo UzukaNoriyoshi TakebeShinichiro KoizumiRyuta SaitoYoshiki ArakawaYoshitaka Naritanull nullPublished in: Japanese journal of clinical oncology (2024)
Treatment of malignant brain tumors is generally expensive, and cost-ineffective treatments such as BEV are frequently used. We believe that the results of this study can be used to design future economic health studies examining the cost-effectiveness of malignant brain tumors.